Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-02-10
DOI
https://doi.org/10.1111/all.16495
Citations
13
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
26.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study

Haihong Qin, Chaoying Gu, Yuemeng Wu, Huibin Yin et al.
13 citations
Allergy
Dermatology and Skin Diseases
26.06
article

Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study

Haihong Qin, Chaoying Gu, Yuemeng Wu, Huibin Yin, Xu Yao, Zheng Li, Yu Wang, Wei Li, Shangshang Wang, Ce Wang, Hao Wu
article en
13 citations

Abstract

No abstract available for this paper.
AllergyVol. 80(5)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fudan University (CN), Chinese Academy of Medical Sciences Dermatology Hospital (CN), Huashan Hospital (CN)
Pfizer, National Natural Science Foundation of China, Shanghai Municipal Education Commission, Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health and Family Planning Commission
Good health and well-being
Openalex Percentile: Top 0%
Dermatology and Skin Diseases
26.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.